Table 3.
The summary estimates of comparisons between negative control and different COVID-19 groups
| Comparison | Studies | Number of individuals | MD (95% CI) | P-value | Heterogeneity |
Egger’s 2-tailed bias p-value | Largest p-value after removing any single study | |
|---|---|---|---|---|---|---|---|---|
| P-value | I[2], % | |||||||
| Negative versus positive SARS-CoV-2 groups | 4 | 392/394 | −1.48 [−1.74, −1.22] | <0.001 | 0.817 | 0 | - | <0.001 |
| Mild versus Moderate | 2 | 103/605 | −1.09 [−1.58, −0.59] | <0.001 | 0.319 | 0 | - | <0.001 |
| Non-severe versus Severe | 18 | 2,780/675 | −7.14 [−8.67, −5.6] | <0.001 | <0.001 | 95.4 | 0.009 | <0.001 |
| Survived versus Died | 7 | 2,380/290 | −15.04 [−23.92, −6.16] | 0.001 | <0.001 | 99.1 | - | 0.034 |
Abbreviations; CI = confidence interval, MD = mean difference, LR = likelihood ratio. Significant differences are in bold.